Funding Details
- Awarder
- Inbox
- Date Award
- August 07, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$72,600,000
Company Info
- Founders
- RA Capital Management
- Company Description
- Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
- Market
- Rare cardiopulmonary disease
- Location
-
Boston,
MA,
USA
- Coinvestors
- Atlas Venture, Cormorant Asset Management, Osage University Partners, RA Capital Management, Sofinnova Partners, Surveyor Capital
Links